BAJAJ BROKING
Mankind Pharma obtained all regulatory approvals, including from CCI, for its ₹13,630 crore acquisition of Bharat Serums and Vaccines. The transaction involves acquiring a 100% stake in BSV.
Mankind Pharma Ltd. has successfully received all the necessary regulatory approvals, including the green light from the Competition Commission of India (CCI), to complete its 100% acquisition of Bharat Serums and Vaccines Ltd. (BSV). The acquisition, valued at ₹13,630 crore, marks a significant milestone in Mankind Pharma's expansion strategy in the biopharmaceutical and vaccine sector.
The company announced the execution of a Share Purchase Agreement on 25 July 2024. The agreement involves the acquisition of Bharat Serums and Vaccines Ltd. from Ansamira Ltd. and Miransa Ltd., affiliates of funds managed by Advent International, along with minority shareholders Bhaskar Iyer and Abhijit Mukherjee. The deal includes acquiring 100% of BSV's shares, making Mankind Pharma a key player in the biopharmaceutical market.
Mankind Pharma disclosed that the transaction is now subject to the completion of customary conditions precedent, as detailed in the Share Purchase Agreements. However, with regulatory hurdles cleared, the acquisition is expected to proceed smoothly.
Bharat Serums and Vaccines Ltd. specialises in the development and manufacturing of biopharmaceuticals, vaccines, and critical-care products, with a portfolio that includes treatments for immunology, oncology, and gynaecology. The acquisition aligns with Mankind Pharma's strategy of expanding its product offerings and tapping into high-growth therapeutic areas. This acquisition is expected to strengthen Mankind Pharma's position in the Indian and global pharmaceutical markets.
The acquisition deal is valued at ₹13,630 crore, positioning it as one of the largest in the Indian pharmaceutical industry this year. The acquisition is anticipated to drive growth for Mankind Pharma by enhancing its presence in key markets and diversifying its product portfolio. Investors will closely watch Mankind Pharma's share price as the company integrates BSV into its operations and explores potential synergies.
Mankind Pharma’s acquisition of Bharat Serums and Vaccines Ltd. is a strategic move that solidifies its position in the biopharmaceutical sector. With regulatory approvals secured, the completion of the transaction is on the horizon, promising growth and market expansion.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Know NTPC Green Energy IPO Review, Objective & Applying Process
14 Nov, 2024 | 1 Min. read
Morgan Stanley Acquires 1.4 Crore PNB Housing Finance Shares for ₹1,336 Crore
14 Nov, 2024 | 2 Min. read
Tata Power Commissions 126 MW Floating Solar Project in Madhya Pradesh
14 Nov, 2024 | 2 Min. read
Cipla Receives US FDA Form 483 with Eight Observations at Bengaluru Unit
14 Nov, 2024 | 2 Min. read
Varun Beverages Opens ₹5,500 Crore QIP, Sets Floor Price at ₹594.56
14 Nov, 2024 | 2 Min. read
NTPC Green Energy IPO: Price Band Set at ₹102-108 Per Share
14 Nov, 2024 | 2 Min. read
Commodities Market Today | Gold Falls for Fourth Session, Oil Rebounds on Short-Covering
14 Nov, 2024 | 1 Min. read
Share Market Today | Gift Nifty Indicates Flat Start for Indian Market Amid Mixed Cues
14 Nov, 2024 | 4 Min. read
Gold Rate Today | Gold Prices Fall for Fourth Straight Session Amid Dollar Gains
14 Nov, 2024 | 2 Min. read
Hindustan Aeronautics Limited Q2 Results FY24-25 Preview | Estimate
14 Nov, 2024 | 1 Min. read
Hero MotoCorp Q2 Results FY24-25 Preview | Estimate
14 Nov, 2024 | 1 Min. read
Samvardhan Motherson International Q2 Results FY24-25 Preview | Estimate
14 Nov, 2024 | 1 Min. read
RBI Launches ULI: Transforming Loan Access
August 27, 2024 | 4 Min. read
Textile Sector in India
September 20, 2024 | 5 Min. read
List of IPOs with DRHPs Filed
November 30, 2023 | 3 Min. read
Aditya Birla Group
September 28, 2023 | 10 Min. read
Bajaj Housing Finance Ltd IPO: Things Smart Investors Need to Know
September 05, 2024 | 4 Min. read
Budget Stock Ideas 2024-2025 | Stocks to Buy Today
July 24, 2024 | 4 Min. read
IPO Eligibility Criteria : Full Details
March 15, 2024 | 6 Min. read
What Is the Lock-In Period in IPOs?
October 18, 2023 | 6 Min. read
Godfrey Phillips Announces 2:1 Bonus Shares
September 16, 2024 | 7 Min. read
Jindal Group- A Comprehensive Analysis
September 27, 2024 | 7 Min. read
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading